Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.

Nuzhat S, Islam MR, Das S, Bashar SJ, Pavlinac PB, Arnold SL, Newlands A, Gibson R, Alvaro EF, Addo J, Khanam F, Ahmed D, Chisti MJ, Qadri F, Ahmed T

Open source

DOI
10.1136/bmjopen-2024-088449
Published
2025 Feb 25
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-088449,
  title = {Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.},
  author = {Nuzhat S and Islam MR and Das S and Bashar SJ and Pavlinac PB and Arnold SL and Newlands A and Gibson R and Alvaro EF and Addo J and Khanam F and Ahmed D and Chisti MJ and Qadri F and Ahmed T},
  year = {2025},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-088449},
  url = {https://doi.org/10.1136/bmjopen-2024-088449}
}

RIS

TY  - JOUR
TI  - Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.
AU  - Nuzhat S
AU  - Islam MR
AU  - Das S
AU  - Bashar SJ
AU  - Pavlinac PB
AU  - Arnold SL
AU  - Newlands A
AU  - Gibson R
AU  - Alvaro EF
AU  - Addo J
AU  - Khanam F
AU  - Ahmed D
AU  - Chisti MJ
AU  - Qadri F
AU  - Ahmed T
PY  - 2025
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-088449
UR  - https://doi.org/10.1136/bmjopen-2024-088449
ER  - 

APA

S, N., MR, I., S, D., SJ, B., PB, P., SL, A., A, N., R, G., EF, A., J, A., F, K., D, A., MJ, C., F, Q., & T, A. (2025). Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2024-088449

Source records